UPCR
Showing 1 - 25 of 175
Dystonia, Parkinson Disease, Essential Tremor Trial in Montpellier (Music Therapy)
Recruiting
- Dystonia
- +2 more
- Music Therapy
-
Montpellier, FranceUnité Pathologies Cérébrales Résistantes (UPCR) - Département de
Mar 16, 2022
Plasmodium Vivax Trial in Vientiane (Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ), Dihydroartemisinin-piperaquine (DP)
Completed
- Plasmodium Vivax
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ)
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ) placebo
-
Vientiane, Lao People's Democratic RepublicLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
Feb 14, 2022
Learn More How Chronic Kidney Disease Gradually Changes Over
Active, not recruiting
- Chronic Kidney Disease
- No Intervention
-
Wuppertal, GermanyBayer
Jun 21, 2023
Adolescent Lupus Nephritis Trial in Orlando (voclosporin)
Not yet recruiting
- Adolescent Lupus Nephritis
-
Orlando, FloridaNemours Children's Health, Lake Nona Medical City
Jul 18, 2023
Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)
Not yet recruiting
- Nephrotic Syndrome
- Dapagliflozin and Standard therapy (ACEI or ARB).
- Standard Therapy (ACEI or ARB).
- (no location specified)
Jul 26, 2023
Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)
Not yet recruiting
- Diabetic Kidney Disease
- IgA Nephropathy
- Placebo of SC0062
- +3 more
- (no location specified)
Jan 9, 2023
Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
Jan 23, 2023
Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)
Not yet recruiting
- Primary IgA Nephropathy
- SHR-2010 Injection
- Placebo
- (no location specified)
Apr 27, 2023
Adolescent Lupus Nephritis Trial in Chapel Hill (Voclosporin, Placebo Oral Capsule)
Not yet recruiting
- Adolescent Lupus Nephritis
- Voclosporin
- Placebo Oral Capsule
-
Chapel Hill, North CarolinaUNC-Chapel Hill
Jun 30, 2022
IgA Nephropathy Trial in China (Telitacicept, Placebo)
Not yet recruiting
- IgA Nephropathy
- Telitacicept
- Placebo
-
Hefei, Anhui, China
- +79 more
Mar 22, 2023
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
- (no location specified)
Apr 27, 2023
Chronic Kidney Disease, Constipation Trial (Constipation treatment)
Not yet recruiting
- Chronic Kidney Disease
- Constipation
- Constipation treatment
- (no location specified)
Nov 8, 2023
Lupus Erythematosus, Systemic Trial in Berlin (CC-97540, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Lupus Erythematosus, Systemic
- CC-97540
- +2 more
-
Berlin, GermanyLocal Institution - 0025
May 22, 2023
IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)
Active, not recruiting
- IgA Nephropathy (IgAN)
- +2 more
- Placebo
- Cemdisiran
-
Vancouver, British Columbia, Canada
- +19 more
Jan 13, 2023
Diabetes, Kidney Transplant; Complications Trial (Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet)
Not yet recruiting
- Diabetes Mellitus
- Kidney Transplant; Complications
- Empagliflozin 25 MG
- Linagliptin 5 mg Oral Tablet
- (no location specified)
Oct 18, 2023
Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)
Not yet recruiting
- Acute Kidney Disease
- Azacitidine
- Placebo
-
Taipei City, TaiwanYu Hsiang Chou
May 2, 2022
Chronic Kidney Diseases Trial in Daejeon (KDSTEM Inj.)
Not yet recruiting
- Chronic Kidney Diseases
- KDSTEM Inj.
-
Daejeon, Chungcheongnam-do, Korea, Republic ofChungnam National University Hospital
Oct 3, 2023
Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)
Not yet recruiting
- Glomerulonephritis Rapidly Progressive
- ALE.F02
- +5 more
- (no location specified)
Sep 14, 2023